← FDA Drug Approvals (Drugs@FDA)

EMTRICITABINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2018-07-02

Drug application

FDA Application #

ANDA091168

Application type

Abbreviated New Drug Application (Generic)

Brand name

EMTRICITABINE

Generic name

EMTRICITABINE

Active ingredients

EMTRICITABINE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2018-07-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown